Home > Boards > US OTC > Medical - Equipment >

Ozop Surgical Corp. (OZSC)

OZSC RSS Feed
Add OZSC Price Alert      Hide Sticky   Hide Intro
Moderator: i_like_bb_stock, DojiMan, DeerBalls, Majk76, Willem Dafoe, Bottom Fisher
Search This Board: 
Last Post: 10/21/2019 3:53:39 PM - Followers: 50 - Board type: Free - Posts Today: 4





 


Share Structure
 
Market Cap - 352,302 - 09/25/2019
Authorized Shares - 990,000,000 - 09/03/2019
Outstanding Shares - 57,337,505 - 09/18/2019
Institutional Holders - 22,229,210 - 09/18/2019
Float - 35,108,295 - 09/18/2019
 
 

COMPANY OVERVIEW

Ozop Surgical Corp. invents, designs, develops, manufactures and globally distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. Our focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers.

OZOP Investor Presentation Spring 2019

OZOP Investor Presentation Spring 2019
 



The Company published 4 new video presentations on 09/11/2019

OZOP Surgical 3D Endoscope
https://www.youtube.com/watch?v=NQNWNeO8VZQ

OZOP Surgical BLIF Procedure
https://www.youtube.com/watch?v=9_vf4no7VNw&t=1s

OZOP Surgical: Expandable ALIF
https://www.youtube.com/watch?v=_VggjtMgKJQ

OZOP Surgical BLIF Technique
https://www.youtube.com/watch?v=jFvIXrt1HDc


OZOP Surgical Corp makes headway on bringing its spine implant tech to market
https://www.youtube.com/watch?v=gX142co1Yhg&t=7s

OZOP Surgical looks to revolutionize spinal surgery with their technology
https://www.youtube.com/watch?v=cG_IX1jIkN4&t=52s

 


THE OZOP SURGICAL STORY

Ozop Surgical Corp. (OTCQB:OZSC), invents, designs, develops, manufactures, and distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies focused on spine, neurological, and pain management procedures and specialties. Our mission is to economically disrupt the orthopedic and neurosurgical markets by providing premium quality surgical devices that result in immediate significant savings for providers, payors, and patients; and to continue to design and manufacture cutting-edge surgical solutions, with an emphasis on our innovations in the rapidly growing field of minimally invasive surgery.

The Company controls an IP portfolio of innovative products and technologies that it is beginning to successfully commercialize. Products in the pipeline include visualization tools for MIS, such as light filtration that presents a better anatomical view of the surgical field in real time, and 3D technology that offers improved depth perception, better visualization of anatomic details, and improved overall surgical performance. Also in development is a revolutionary orthopedic device and procedure, the first truly MIS interbody device and fusion procedure.
 



OZOP SURGICAL EXECUTIVE MANAGEMENT TEAM
 

Michael Chermak,  CEO, Chairman

michael@ozopsurgical.com

Michael Chermak has over 30 years of experience in healthcare-related ventures. Previously, he was the founder and CEO of Healthdemographics, Inc., a company in the healthcare predictive data and decision support business. Healthdemographics had over 1,200 clients worldwide and was regularly cited by the Wall Street Journal in articles about the healthcare industry. He sold the company in 1997 to Medirisk.

In 1998, he was the co-founder, initial investor, and original Chairman of Medibuy.com, an Internet healthcare supply vendor. Medibuy raised over $140 million in its first 18 months of operation backed by leading VCs such as Kleiner Perkins, Sequoia, Oak, and institutional investors including Alianz. Medibuy acquired the ecommerce initiatives of two leading GPOs, Premier and Columbia HCA, that at one time accounted for nearly 70% of healthcare product expenditures in the US. Medibuy was sold to GHX (Global Health Exchange), an ecommerce company founded by General Electric, Abbot, Baxter, Medtronic. Becton-Dickinson, Braun, Guidant, Tyco, Siemens, and others.

He worked in China for over 6 years and was the former Chairman and CEO of Bridgetech Holdings International (OTC: BGTH), which focused on introducing Western medicine into China. He has served on the Board of Directors and as an Audit Committee member of Beijing Origin Seed (NASDAQ: SEED).

Michael graduated from the University of New Mexico, Anderson School of Management. Michael and his wife fund and run a 501(c)(3) focused on animal rescue and the support of rescue organizations.
 



Tom McLeer,  Chief Operating Officer, Director

tom@ozopsurgical.com

Tom McLeer brings over 30 years of commercial operations experience in orthopedics, spine and orthobiologics. He is a proven medical device leader who has boosted sales for existing companies and led startups through regulatory approval and into full commercialization. He holds numerous patents in the spine and orthopedic space.

He most recently served as Vice President of Sales and Marketing at LinkSpine.  Previously he was Senior Vice President of US Commercial Operations for Alphatec Spine, Global CMO and General Manager of Spinal Operations for Pioneer Surgical (sold to RTI) and VP of Sales and Marketing for Archus Orthopedics.  Earlier in his career, McLeer was VP of Marketing and Business Development for Spinal Concepts (sold to Abbott labs) and VP of Marketing for Interpore Cross International.

Tom holds a B.S. in Business Administration from The Ohio State University and a MBA from the Kellogg School of Management at Northwestern University.
 



Barry Hollander,  Chief Financial Officer

barry@ozopsurgical.com

Barry Hollander has 38 years of business experience, including 20 years as Chief Financial Officer of various private and public companies. In 2010, Mr. Hollander founded Venture Equity, LLC, a Florida-based company that offers financial and business consulting services. He was named Chief Financial Officer of Cabinet Grow, Inc. (“CBNT”) on May 14, 2014, and is also the current CEO of CBNT. Since 2011, Mr. Hollander has been the Chief Financial Officer of Agritek Holdings, Inc. (“Agritek”), formerly known as MediSwipe, Inc. Agritek provides real estate management and health and wellness product lines for the medicinal marijuana industry.

Barry began his career in 1981 in the accounting department of Macgregor Sporting Goods, and rose through the ranks to become a critical part of the executive management team. Over his career, Barry contributed to mergers and acquisitions, assisting companies preparing to go public and taking on public reporting responsibilities. He holds a degree from Fairleigh Dickinson University.
 



Nick Ansari, Executive Vice President, Sales & Marketing

nick@ozopsurgical.com

Nick Ansari has more than 25 years of experience in the medical device field. Over the course of his career, he has amassed an impressive track record in defining strategies and executing initiatives that drive revenue and strengthen market shares for startup, turnaround, and rapid-growth medical device companies. Nick has an in-depth understanding of markets, products, customers, and competitors, which helps him deliver strategic and tactical blueprints to ensure success in US and international environments. He leverages his comprehensive experience in business development, P&L management, strategic planning, forecasting, sales force leadership, asset analysis, product training, and market expansion to exceed projections time and again.

Nick has previously held senior leadership positions in various medical device companies, including Stryker, Medtronic, Globus, and Lanx/Biomet-Zimmer. As an executive-level team player, he has assisted mergers and acquisitions in the private and public medical device sectors—namely, when Biomet, ZBH purchased Lanx ($147 million); when RSLS, Reshape Lifesciences purchased Bario Surge; and when RSLS purchased Lap-Band from Apollo Endosurgery, APEN.
 



Eric Siu, Director of Endoscopic Program Development

Eric Siu has been focused on endoscopic surgical approaches for more than 25 years. He has spent over a decade creating IP and developing minimally invasive endoscopic products, including four different neuroendoscopic systems (Viewing Endoscope, Pituitary Endoscope, Intraventricular Endoscope, Subcortical Space endoscope with visible tube) and four types of spine endoscopes (MED, MED with retractor, PELD and Cervical). Eric currently holds dozens of patents in the PRC and abroad.

OZOP is an extension of his expertise on Spine and Neuro endoscopes; and his focus on molecular MIS recognizes the future potential for endoscope systems. His experience in product development and in the laboratory add stability and bring tremendous value to the company as it pursues its great future.

Eric has established academic research collaborations with the Chinese University of Hong Kong and Hong Kong University as well as leading institutions in the PRC. He has a long history of collaboration with the MOH (Ministry of Health), where he has organized over 200 workshops for leading Chinese surgeons working with international medical device manufacturers as well as the CDA (Chinese Doctors Association) regarding physician and surgeon training and continuing education initiatives. He also has extensive experience in working with China’s regulatory body, the CFDA, and has successfully registered over 100 products for international medical devices manufacturers.

Eric has maintained an office in Tuttlingen, Germany for over 15 years; from that location, he has sourced products for introduction and sale in the PRC. Eric, a Canadian citizen based in Hong Kong and Beijing, holds degrees in Applied Mathematics and Physics from the University of London.

  


For distributor inquiries, please email:
distributor@ozopsurgical.com

If you have products that you would like us to distribute:
product@ozopsurgical.com

For all other inquiries:
info@ozopsurgical.com

866-286-1055
 



INVESTOR RELATIONS

MZ Group - MZ North America
Ted Haberfield
President
T: 760-755-2716
thaberfield@mzgroup.us
www.mzgroup.us

TRANSFER AGENT

VStock Transfer LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
www.vstocktransfer.com

AUDITOR

Prager Metis CPAs LLC
15 Warren Street
Suite 25
Hackensack, NJ 07601

LEGAL COUNSEL

Anthony L.G., PLLC
330 Clematis Street
No. 217
West Palm Beach, FL 33401
 


 
OTC DISCLOSURE & NEWS SERVICE
 
OZSC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OZSC News: Current Report Filing (8-k) 10/15/2019 04:14:19 PM
OZSC News: Information Statement - All Other (definitive) (def 14c) 10/15/2019 08:02:20 AM
OZSC News: Current Report Filing (8-k) 10/07/2019 05:15:09 PM
OZSC News: Proxy Statement - Other Information (preliminary) (pre 14c) 10/04/2019 04:14:27 PM
OZSC News: Notice of Effectiveness (effect) 10/02/2019 06:00:57 AM
PostSubject
#1255  Sticky Note Soon as the 8-K is posted this will TJG 10/03/19 09:51:39 AM
#610  Sticky Note Ozop Surgical Corp. updated Share Structure + Latest News Majk76 09/23/19 12:44:14 PM
#324  Sticky Note Exclusive License Agreement With Spinal Resources Inc. Announced Bottom Fisher 09/17/19 04:36:11 PM
#1478   OZSC Company is a Top 10 Orthopedic solution provider sharky 10/21/19 03:53:38 PM
#1477   slow day The Night Stalker 10/21/19 03:42:55 PM
#1476   0 volume, complete dud z1z2z3 10/21/19 10:29:04 AM
#1475   Gm all, looking forward to the week ahead $$$$$ sharky 10/21/19 09:29:11 AM
#1474   $ OZSC .0105 +5.00% CEO Michael Chermak jedijazz 10/18/19 10:05:10 AM
#1473   Gm all .011's up sharky 10/18/19 09:31:15 AM
#1472   Great Picture Sharky. Looks like a bigger version Jeffster1 10/17/19 02:10:28 PM
#1471   OZSC patents: sharky 10/17/19 12:18:44 PM
#1470   OZSC OZOP SURGICAL EXECUTIVE MANAGEMENT TEAM sharky 10/17/19 12:15:10 PM
#1469   The exclusive License Agreement allows Ozop to sell sharky 10/17/19 12:14:21 PM
#1468   Agreed! Distantpulse 10/17/19 11:10:37 AM
#1467   Current estimated O/S is around 81M from the Laylos 10/17/19 09:36:08 AM
#1466   There are definitely more runs to come the Laylos 10/17/19 06:43:59 AM
#1465   https://www.barchart.com/stocks/quotes/OZSC/technical-chart?plot=CANDLE&volume=t The Night Stalker 10/17/19 01:03:33 AM
#1464   This team is on it! Just getting hospital Jeffster1 10/16/19 10:40:17 PM
#1463   Revenue ramp-up underway with pathway to operating profit dpm58 10/16/19 03:14:45 PM
#1462   Think? Hope? It's a gamble. And at a JoshTaeger 10/16/19 02:32:28 PM
#1461   Oh, so you think there will be another z1z2z3 10/16/19 02:08:31 PM
#1460   No, not at all. But I'm into OZSC JoshTaeger 10/16/19 02:07:27 PM
#1459   Thanks. Seen this in other OTCs. Sometimes there's JoshTaeger 10/16/19 02:05:47 PM
#1458   So what you're saying is run for the hills? z1z2z3 10/16/19 01:53:27 PM
#1457   Its good 2 see people reading the filings Werbe 10/16/19 01:44:18 PM
#1456   Great post Josh, many do not understand how TJG 10/16/19 01:37:13 PM
#1455   #10 on breakout boards sharky 10/16/19 01:30:17 PM
#1454   Lowest trade in last 20 days was 0.0081. JoshTaeger 10/16/19 01:24:43 PM
#1453   Platinum Point Capital new note holder, given instant Werbe 10/16/19 12:58:24 PM
#1452   Sounds promising. Still the price drops. Lol Distantpulse 10/16/19 12:44:24 PM
#1451   Michael Chermak, Chief Executive Officer of OZOP, commented, jedijazz 10/16/19 12:19:14 PM
#1450   Ozop Surgical Corp. Revenue ramp-up underway with pathway jedijazz 10/16/19 12:18:46 PM
#1449   Where is that post and timeline for the z1z2z3 10/16/19 12:05:00 PM
#1448   Maj contacted the company not to far back, Laylos 10/16/19 12:01:55 PM
#1447   not sure where these shares are coming from? NewTrader2017 10/16/19 11:48:07 AM
#1446   Where did they say they had more news? z1z2z3 10/16/19 11:42:35 AM
#1445   What a POS this is. Smdh..... Distantpulse 10/16/19 11:39:50 AM
#1444   I said in my first post today that TJG 10/16/19 11:00:07 AM
#1443   This weeks out come is enough proof they stockstalk09 10/16/19 10:56:43 AM
#1442   SEC regs is why the 8-K had to TJG 10/16/19 10:32:10 AM
#1441   $OZSC Ozop Surgical Corp. Announces an Update to StockHighAlert- 10/16/19 10:25:36 AM
#1440   The nerd has to be stock market stupid stockstalk09 10/16/19 10:19:50 AM
#1439   Need the new millions in revenue to sure Laylos 10/16/19 10:09:47 AM
#1438   That's the key word right there, dilutive 8-K, stockstalk09 10/16/19 10:06:09 AM
#1437   Almost through that mill now. Laylos 10/16/19 10:00:59 AM
#1436   Idiot CEO lead with dilution 8K and then TJG 10/16/19 09:54:28 AM
#1435   Right now that million+ shares that got bought Laylos 10/16/19 09:54:19 AM
#1434   Pretty thin after 0.011...news is validation of the Laylos 10/16/19 09:52:39 AM
#1433   We have problems if the market does not TJG 10/16/19 09:39:50 AM
#1432   $ OZSC .014 +19.66% on NEWS as Ozop Surgical jedijazz 10/16/19 09:38:20 AM
#1431   Great News! Huge for revenue growth and battling Laylos 10/16/19 09:38:18 AM
#1430   https://www.otcmarkets.com/stock/OZSC/news/Ozop-Surgical-Corp-Announces-an-Updat z1z2z3 10/16/19 09:36:23 AM
#1429   News out! Big buys to start the day too. z1z2z3 10/16/19 09:33:29 AM
PostSubject